ENTITY

Insulet Corp (PODD US)

84
Analysis
Health Care • United States
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
more
bullish•Eoflow
•26 Oct 2023 05:12

Medtronic's M&A of Eoflow Timeline Postponed

​The M&A between Eoflow and Medtronic has been postponed, with a new closing date set for January 3, 2024. The tender offer price may be lowered to...

Logo
1k Views
Share
bearish•Eoflow
•25 Oct 2023 20:54

EOFLOW/Medtronic Tender: Closing Date Extended to 3 January 2024

The bulls would say that the closing extension date suggests a done deal. The bears would say the move was Medtronic’s only move to retain option...

Logo
870 Views
Share
bearish•Eoflow
•23 Oct 2023 17:14

Merger Arb Mondays (23 Oct) - Eoflow, Celltrion Healthcare, JSR, Origin, Lithium Power, Poly Culture

This week, the highest gross spreads are 111 (64.9%), Eoflow (38.2%), Hollysys (30.1%), JSR (8.2%), Haitong Intl (7.8%), LPI (7.5%), Orecorp...

Logo
738 Views
Share
bearish•Eoflow
•16 Oct 2023 00:36

EOFLOW/Medtronic Tender: Pretrial Timetable and Latest Court Filings

We examine the latest court filings and highlight critical information to help investors in their decision-making process regarding this...

Logo
1k Views
Share
bullish•Eoflow
•11 Oct 2023 22:13

Eoflow: Temporary Trading Suspension

On 10 October, KRX announced a temporary suspension of trading of Eoflow starting 11 October. We provide various scenario analysis including the...

Logo
745 Views
Share
x